Reports contain similar claims of GI side effects, particularly in off-label or long-term users
Starting with the lowest effective doses of both compounds and gradually titrating upward allows for better symptom monitoring and safety assessment
J Urol 81 : 770772 Weidner W (1999) Randomized prospective placebo-controlled therapy of Peyronie's disease (IPP) with Potaba (aminobenzoate potassium)
The Step-by-Step Reconstitution Protocol: Our Method Alright, you've got your supplies and a clean workspace
How does a history of gallbladder disease affect GLP-1 eligibility
Lancet 389:528537 Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE (1985) Efficacy of low-dose methotrexate in rheumatoid arthritis